Review Article
Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer
Figure 1
Patients A and B were diagnosed with advanced ovarian cancer. Pretreatment F-18 FDG PET imaging successfully visualized multiple cancerous lesions in the neck and abdominal cavity. However, the imaging was not able to predict the therapeutic response to the subsequent chemotherapy. Patient A achieved complete remission after chemotherapy; however, patient B progressed to disease status after chemotherapy.